Patient preferences for elagolix and leuprolide for treating endometriosis-related pain in the United States-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Patient preferences for elagolix and leuprolide for treating endometriosis-related pain in the United States

Published:2020-11-03 Issue:5 Volume:21 Page:1091-1099
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Poulos Christine¹^ORCID,Soliman Ahmed M.²,Tekin Sibel²,Agarwal Sanjay K.³

Affiliation:

1. Health Preference Assessment, RTI Health Solutions, Research Triangle Park, NC, USA

2. Health Economics and Outcomes Research (HEOR), AbbVie Inc, North Chicago, IL, USA

3. Center for Endometriosis Research and Treatment, University of California San Diego, La Jolla, CA, USA

Funder

AbbVie Inc. RTI Health Solutions

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2021.1832468

Reference23 articles.

1. Prevalence and Symptomatic Burden of Diagnosed Endometriosis in the United States: National Estimates from a Cross-Sectional Survey of 59,411 Women

2. Differences in characteristics among 1,000 women with endometriosis based on extent of disease

3. Peripheral changes in endometriosis-associated pain

4. How to Understand the Complexity of Endometriosis-Related Pain

5. Management of Endometriosis-associated Pain

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioequivalence of Elagolix/Estradiol/Norethindrone Acetate Fixed‐Dose Combination Product: Phase 1 Results in Healthy Pre‐ and Postmenopausal Women;Clinical Pharmacology in Drug Development;2024-04-09

2. A discrete-choice experiment study of physicians’ prioritization of attributes of medical treatments for endometriosis-associated pain;Expert Review of Pharmacoeconomics & Outcomes Research;2023-01-02

3. Endometriosis in the Mouse: Challenges and Progress Toward a ‘Best Fit’ Murine Model;Frontiers in Physiology;2022-01-13

4. Analysis of the clinical efficacy of leuprolide acetate in the treatment of obese patients with endometriosis and its role on the expression of MIF gene;Cellular and Molecular Biology;2022-01-02

5. Elagolix in the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women;Expert Review of Clinical Pharmacology;2021-03-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3